Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis

Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis. The aim of this study was to establish whether there is a differential effect of mode of dialysis, hemodialysis (HD), or continuous ambulatory peritoneal dialysis (CAPD) on the dyslipidemia of renal failure....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 1999-04, Vol.55 (4), p.1536-1542
Hauptverfasser: Attman, Per-Ola A., Samuelsson, Ola G., Moberly, James, Johansson, Ann-Cathrine, Ljungman, Susanne, Weiss, Lars G., Knight-Gibson, Carolyn, Alaupovic, Petar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis. The aim of this study was to establish whether there is a differential effect of mode of dialysis, hemodialysis (HD), or continuous ambulatory peritoneal dialysis (CAPD) on the dyslipidemia of renal failure. The lipoprotein profile was determined in 61 nondiabetic patients on chronic HD (N = 30) and CAPD treatment (N = 31), and in a control group of 27 healthy subjects. The analysis included the measurement of individual apolipoprotein (apo) A- and apo B-containing lipoproteins (LPs) separated by sequential immunoaffinity chromatography. Apo A-containing lipoproteins include lipoprotein A-I with apo A-I and lipoprotein A-I:A-II with apo A-I and apo A-II as the main protein constituents, whereas apo B-containing lipoproteins comprise simple cholesterol-rich lipoprotein B (LP-B), with apo B as the only protein moiety and complex triglyceride (TG)-rich lipoprotein B complex (LP-Bc) particles with apo B, apo A-II, apo C, and/or apo E as the protein constituents. CAPD patients had significantly higher concentrations of total cholesterol (6.8 vs. 5.1mmol/liter), low-density lipoprotein (LDL) cholesterol (4.6 vs. 3.2mmol/liter), TG (2.3 vs. 1.5mmol/liter), apo B (155.3 vs. 105.7mg/dl), LP-B (136.0 vs. 91.9mg/dl), and LP-Bc (19.3 vs. 13.8mg/dl) than HD patients. Both HD and CAPD patients had significantly higher TG, VLDL cholesterol, apo C-III, and apo E and significantly lower high-density lipoprotein cholesterol, apo A-II, and lipoprotein A-I:A-II levels than control subjects. The distribution of apo C-III in high-density lipoprotein and VLDL-LDL was altered in CAPD patients in comparison with control subjects. This suggests that the removal of TG-rich lipoproteins is less efficient in patients on CAPD. Normotriglyceridemic (NTG; TG ≤ 1.7mmol/liter, 150mg/dl) CAPD patients had significantly higher levels of TC, LDL cholesterol, apo B, and LP-B than NTG-HD patients. There was little difference in the LP-Bc levels between NTG-CAPD, NTG-HD, and controls. Similarly, hypertriglyceridemic (HTG) CAPD patients had significantly higher TC, LDL cholesterol, apo B, and LP-B levels than HTG-HD patients. The LP-Bc levels were significantly increased in HTG-HD and HTG-CAPD patients compared with controls, but the slightly higher levels in the CAPD patients did not differ significantly from the HD group. CAPD and HD patients have a lipoprotein profile characteristic of renal failure. P
ISSN:0085-2538
1523-1755
DOI:10.1046/j.1523-1755.1999.00375.x